StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by NewToInvesting7on Sep 22, 2020 2:58pm

118 Views

Post# 31598408

RE:RE:RE:RE:CIBC....

I spoke to CIBC today, and were told that "there was a 1 for 8 reverse split that occurred on 09/18/20 and CIBC is currently awaiting the updated certificates to arrive from the company (SZLS). In the meantime, if anyone needs to sell, please give CIBC a call at 1-800-567-3343 and speak to a trader as they can place the order for you".

Nailbiter1 wrote:

skier59 wrote: I don't think they have to notify the banks, as the banks are supposed to follow directives of the TSX.

They are slower than usual. Working from home slows a pile of stuff.
Tripp does have an obligation to make sure all the banks are settled before releasing news to optimize its effect.